Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s Why Investors Are Watching Caterpillar, Sensata Technologies & Three Other Stocks

The US stock market is mixed on Friday, as investors await the conclusion of the Fed’s FOMC two-day meeting that started today and amid a drop in crude futures below $43 per barrel.

Viking Therapeutics Inc (NASDAQ:VKTX), Caterpillar Inc. (NYSE:CAT), Sensata Technologies Holding N.V. (NYSE:ST), Ally Financial Inc (NYSE:ALLY), and McDonald’s Corporation (NYSE:MCD) are trending today for various reasons. In this article, we examine why traders are buying and selling the five stocks and take a look what the hedge funds and other investors tracked by our team think about the companies in question.

Hedge fund sentiment is an important metric for assessing the long-term profitability. At Insider Monkey, we track over 700 hedge funds, whose quarterly 13F filings we analyze and determine their collective sentiment towards several thousand stocks. However, our research has shown that the best strategy is to follow hedge funds into their small-cap picks. This approach can allow monthly returns of nearly 95 basis points above the market, as we determined through extensive backtests covering the period between 1999 and 2012 (see the details here).

Viking Rises on Positive Proof-of-Concept Results

Nano-cap Viking Therapeutics Inc (NASDAQ:VKTX) shares are in the green today after a proof-of-concept showed positive top-line results in which the company’s product candidate VK0214 rapidly reduced plasma very long chain fatty acid levels by more than 25% in treated animals compared with vehicle controls. The study achieved its primary objective of lowering plasma VLCFA levels after six weeks of treatment and the company plans to present detailed results at an upcoming scientific meeting. None of the elite funds we track owned shares of Viking Therapeutics Inc (NASDAQ:VKTX) at the end of March. As with all nano-caps, traders should do due-diligence both buying and selling.

Caterpillar Beats 

A few days after Komatsu bought out Joy Global, Caterpillar Inc. (NYSE:CAT) reported solid second-quarter results with EPS of $1.09 on sales of $10.34 billion, beating the consensus estimates by $0.13 per share and $280 million, respectively. Caterpillar beat estimates largely because management was successful in controlling costs and improving efficiency. Despite the beat, weak global macro-economic conditions will likely still weigh on the company’s results. Management sees 2016 revenue coming in at the bottom of the previously guided range of $40 billion to $42 billion, at around $40-$40.5 billion. Management also expects full-year profit coming in at around $2.75 per share in terms of GAAP earnings and at around $3.55 per share, when excluding restructuring costs. The number of investors from our database with holdings in Caterpillar Inc. (NYSE:CAT) rose by six to 37 during the first quarter.

Follow Caterpillar Inc (NYSE:CAT)
Trade (NYSE:CAT) Now!

On the next page, we examine why Sensata Technologies Holding NV, Ally Financial, and McDonald’s Corporation are in the spotlight.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.